Cole Schmidtknecht, 22, couldn't pay for his daily inhaler due to the “prohibitively expensive” price increase, but then he ...

While the FTSE 100 powers higher, Wall Street remains contained following its rebound earlier in the week, says Chris ...

GSK, a UK-based biopharma, reported strong 2024 results, with a promising shift toward specialty medicines. Read why I ...

Further gains propel the ounce troy of Gold to all-time highs near the $2,880 mark on the back of the weak US Dollar, ...